Form 424B5 Genelux Corp For: 8 January
- Investing.com
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Genelux Corp (GNLX)
Assess today's live Genelux Corp (GNLX) share price, performance and insights using our live NASDAQ: GNLX stock exchange data.
Analyse the historical data and Genelux Corp share price performance charts on this page. Our technical summary section provides analysis on Genelux share price buy/sell indicators using real-time data (or discuss the Genelux (GNLX) stock price today with other investors in the Genelux NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ GNLX share price (ISIN: US36870H1032) to enhance your trading decisions with our free investment tools and resources.
What Is the Genelux Corp Share Price Today?
The Genelux share price today is 2.870.
What Is the Stock Symbol for Genelux Corp
The stock symbol (or 'ticker') for Genelux Corp is "GNLX."
What Stock Exchange Does Genelux Corp Trade On?
Genelux Corp is listed and trades on the NASDAQ stock exchange.
Is Genelux Corp a Good Stock to Buy?
Determining whether Genelux Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Genelux Corp share price performance charts on this page. Our technical summary section provides analysis on Genelux share price buy/sell indicators using real-time data (or discuss the Genelux (GNLX) stock price today with other investors in the Genelux NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ GNLX share price (ISIN: US36870H1032) to enhance your trading decisions with our free investment tools and resources.
What Is the Genelux Corp Share Price Today?
The Genelux share price today is 2.870.
What Is the Stock Symbol for Genelux Corp
The stock symbol (or 'ticker') for Genelux Corp is "GNLX."
What Stock Exchange Does Genelux Corp Trade On?
Genelux Corp is listed and trades on the NASDAQ stock exchange.
Is Genelux Corp a Good Stock to Buy?
Determining whether Genelux Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.770
2.890
52 wk Range
1.987
8.535
GNLX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.7702.890
52 wk Range
1.9878.535
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
GNLX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
19.333
Upside
+573.64%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
- Form 424B5 Genelux Corp For: 8 January
- Investing.com
- Form 424B5 Genelux Corp For: 7 January
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Genelux Company Profile
Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Its lead product candidate is Olvi-Vec, a proprietary modified strain of the vaccinia virus indicated for the treatment of ovarian cancer and non-small cell lung cancer, as well as for liquid or solid tumors, appendiceal, colorectal and gastric cancers, other gynecologic malignancies, and peritoneal mesothelioma. The company has a licensing agreement with Newsoara BioPharma Co. Ltd. to research, develop, commercialize or exploit Olvi-Vec in China, including Mainland China, Taiwan, Hong Kong, and Macau, for human diagnostic, prophylactic, and therapeutic uses. Genelux Corporation was incorporated in 2001 and is headquartered in Westlake Village, California.
Compare GNLX to Peers and Sector
Metrics to compare | GNLX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipGNLXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −4.0x | −1.9x | −0.6x | |
PEG Ratio | −0.63 | 0.28 | 0.00 | |
Price/Book | 6.8x | 2.3x | 2.6x | |
Price / LTM Sales | - | 23.5x | 3.4x | |
Upside (Analyst Target) | - | 206.6% | 42.0% | |
Fair Value Upside | Unlock | −0.5% | 5.0% | Unlock |
Analyst Ratings
6 Buy
0 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 19.333
(+573.64% Upside)
Earnings
Latest Release
Nov 05, 2025
EPS / Forecast
-0.21 / -0.22
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Is the Genelux (GNLX) Share Price Today?
The live Genelux share price today is 2.870
What Stock Exchange Does Genelux (GNLX) Trade On?
Genelux is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Genelux?
The stock symbol (also called a 'ticker') for Genelux is "GNLX."
What Is the Current Genelux Market Cap?
As of today, Genelux market capitalisation is 127.54M.
What Is Genelux's (GNLX) Earnings Per Share (TTM)?
The Genelux EPS is currently -0.88 (Trailing Twelve Months).
When Is the Next Genelux Earnings Date?
Genelux's next earnings report will be released on 05 Apr 2026.
Is GNLX a Buy or Sell From a Technical Analyst Perspective?
Based on today's Genelux moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Genelux Stock Split?
Genelux has split 0 times. (See the GNLX stock split history page for full effective split date and price information.)
How Many Employees Does Genelux Have?
Genelux has 24 employees.
What is the current trading status of Genelux (GNLX)?
As of 24 Jan 2026, Genelux (GNLX) is trading at a price of 2.870, with a previous close of 2.880. The stock has fluctuated within a day range of 2.770 to 2.890, while its 52-week range spans from 1.987 to 8.535.
What Is Genelux (GNLX) Price Target According to Analysts?
The average 12-month price target for Genelux is USD19.333, with a high estimate of USD31 and a low estimate of USD10. 6 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +573.64% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.